No Record Found
Sector
HealthcareOpen
₹2,030Prev. Close
₹2,041.1Turnover(Lac.)
₹682.69Day's High
₹2,031.9Day's Low
₹1,991.152 Week's High
₹2,318.352 Week's Low
₹1,315Book Value
₹245.55Face Value
₹2Mkt Cap (₹ Cr.)
10,342.32P/E
80.06EPS
24.92Divi. Yield
0The deal includes a deferred payment of ₹1.7 crore, which will be disbursed as per the terms of the business transfer agreement, the company said in a regulatory filing.
The EBITDA margin fell to 18% in Q4 FY25 from 24.2% in Q4 FY24, reflecting a fall in operational efficiency or profitability.
The EBITDA margin was stable at 22.3% and did not change much from the year-ago period.
This is a 100% stake purchase that will be funded through 55% cash and 45% equity swap. It expects completion in 60 days, after shareholders give their nod.
Here are some of the stocks that may see significant price movement today: Tata Motors, Asian Paints, Divi’s Laboratories, etc.
Y/e 31 Mar( In .Cr) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 |
---|---|---|---|---|
Equity Capital | 18.28 | 17.98 | 10.24 | 10.23 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 1,226.16 | 1,013.21 | 925.77 | 828.97 |
Net Worth | 1,244.44 | 1,031.19 | 936.01 | 839.2 |
Minority Interest |
Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2017 |
---|---|---|---|---|
Revenue | 1,117.13 | 961.38 | 665.3 | 404.66 |
yoy growth (%) | 16.19 | 44.5 | 64.4 | |
Raw materials | -252.67 | -244.23 | -167.24 | -101.87 |
As % of sales | 22.61 | 25.4 | 25.13 | 25.17 |
Employee costs | -210.12 | -188.24 | -147.66 | -94.64 |
Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2017 |
---|---|---|---|---|
Profit before tax | 245.87 | 242.12 | 164.51 | 131.41 |
Depreciation | -55.88 | -43.78 | -30.84 | -12.18 |
Tax paid | -69.53 | -59.47 | -27.93 | -43.4 |
Working capital | -234.23 | 238.14 | 223.59 | |
Other operating items |
Y/e 31 Mar | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2017 |
---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 16.19 | 44.5 | 64.4 | |
Op profit growth | 8.46 | 62.95 | 44.23 | |
EBIT growth | 6.16 | 46.01 | 29.83 | |
Net profit growth | 5.24 | 63 | 27.32 |
Particulars (Rupees in Crores.) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
---|---|---|---|---|---|
Gross Sales | 1,331.2 | 1,207.71 | 1,148.21 | 1,228.34 | 997.99 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 1,331.2 | 1,207.71 | 1,148.21 | 1,228.34 | 997.99 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 15.11 | 9.12 | 15.22 | 33.52 | 12.05 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
---|---|---|---|---|---|---|---|
Apollo Hospitals Enterprise Ltd APOLLOHOSP | 7,449.5 | 79.19 | 1,07,020.36 | 306.9 | 0.17 | 2,167.9 | 607.44 |
Max Healthcare Institute Ltd MAXHEALTH | 1,069.2 | 136.01 | 1,03,936.94 | 166.03 | 0.14 | 694.02 | 85.26 |
Fortis Healthcare Ltd FORTIS | 980.4 | 420.64 | 73,993.45 | 51.88 | 0.1 | 433.03 | 120.19 |
Narayana Hrudayalaya Ltd NH | 1,753 | 82.9 | 35,813.21 | 87.37 | 0.26 | 943.14 | 107.01 |
Global Health Ltd MEDANTA | 1,328.8 | 71.17 | 35,698.05 | 151.96 | 0 | 882.16 | 130.12 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman Emeritus
Sushil Kanubhai Shah
Chairperson & Whole Time Direc
Ameera Sushil Shah
Independent Non Exe. Director
VIVEK GAMBHIR
Independent Non Exe. Director
Sanjay Bhatnagar
Non-Exec & Non-Independent Dir
Hemant Sachdev
Independent Non Exe. Director
Subramanian Ranganathan
Non-Exec & Non-Independent Dir
Aparna Rajadhyaksha
Independent Non Exe. Director
Purvi Sheth
Managing Director & CEO
Surendran Chemmenkotil
Independent Non Exe. Director
REHAN KHAN ABBAS
CS / Compliance Officer / Legal Head
Kamlesh C Kulkarni
250 D Udyog Bhavan,
Worli,
Maharashtra - 400030
Tel: 91-22-62582810
Website: http://www.metropolisindia.com
Email: investor.relations@metropolisindia.com
C-101 247 Park,
L B S Marg, Vikhroli West,
Mumbai-400083
Tel: 91-22-49186000
Website: www.linkintime.co.in
Email: paytm.ipo@linkintime.co.in
Summary
Dr. Sushil Kanubhai Shah, one of the Promoters, commenced pathology business in January 1980 as a partnership firm in the name of Dr. V. K. Desais Hospital, having Dr. Kanubhai M. Shah, Dr. Sushil Kan...
Read More
Reports by Metropolis Healthcare Ltd
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.